« Previous Next » Nuclear Medicine and Biology
Volume 33, Issue 3 , Pages 295-304 , April 2006

Nicotinic α4β2 receptor imaging agents: Part II. Synthesis and biological evaluation of 2-[¹⁸F]fluoro-3-[2-((S)-3-pyrrolinyl)methoxy]pyridine (¹⁸F-nifene) in rodents and imaging by PET in nonhuman primate

Presented in part at the 52nd Annual Society of Nuclear Medicine Meeting, Toronto, Canada, June 18–23, 2005.

Rama Pichika
- Brain Imaging Center, Department of Psychiatry and Human Behavior, University of California, Irvine, CA 92697-3960, USA
Balasubramaniam Easwaramoorthy
- Brain Imaging Center, Department of Psychiatry and Human Behavior, University of California, Irvine, CA 92697-3960, USA
Daphne Collins
- Brain Imaging Center, Department of Psychiatry and Human Behavior, University of California, Irvine, CA 92697-3960, USA
Bradley T. Christian
- Department of Nuclear Medicine, Kettering Medical Center, Dayton, OH 45429, USA
Bingzhi Shi
- Department of Nuclear Medicine, Kettering Medical Center, Dayton, OH 45429, USA
Tanjore K. Narayanan
- Department of Nuclear Medicine, Kettering Medical Center, Dayton, OH 45429, USA
Steven G. Potkin
- Brain Imaging Center, Department of Psychiatry and Human Behavior, University of California, Irvine, CA 92697-3960, USA
Jogeshwar Mukherjee
- Brain Imaging Center, Department of Psychiatry and Human Behavior, University of California, Irvine, CA 92697-3960, USA
- Corresponding author. Tel.: +1 949 824 2018; fax: +1 949 824 4144.